Back

How do guidelines recommendations on GLP-1RA affect clinical practice?

28 August 2021 (11:30 - 11:37)
Organised by:
Congress Presentation Part of: Glucagon-like peptide 1 receptor agonists in clinical cardiology practice Risk Factors and Prevention Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Erin Bohula

Brigham and Women's Hospital, Boston (United States of America)

2 More presentations in this session

Presentation thumbnail
Practical applications of GLP-1RAs.
Doctor M. Kosiborod (Kansas City, US)
Video
Presentation thumbnail
Discussion.
Doctor E. Bohula (Boston, US) Doctor M. Kosiborod (Kansas City, US)
Video

Access the full session

Session thumbnail
Glucagon-like peptide 1 receptor agonists in clinical cardiology practice
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Practical considerations for the use of GLP-1 RAs in the clinic.
28 August 2022
thumbnail
Webinar
GLP-1 RAs and HFpEF : what do we know from large RCTs about GLP-1 RAs and their effects on HFpEF?
24 November 2025
thumbnail
Congress Presentation
GLP-1 receptor agonists added to guideline-directed medical therapy in heart failure with reduced ejection fraction: a propensity score-matched analysis
30 August 2026
thumbnail
Congress Presentation
GLP1-RA versus metformin as first-line therapy for achieving glycemic control and risk-factor management - a one-year nationwide cohort study
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources